Locations:
March 25, 2021/Neurosciences/Spine Care

Ventral and Dorsal Surgical Approaches Perform Equally Well in Study of Cervical Spondylotic Myelopathy

No differences in patient-reported physical functioning at one year

imaging study showing cervical spondylotic myelopathy in the neck

One year after surgery for cervical spondylotic myelopathy, patients report similar improvement in physical and general health measures regardless of whether they underwent a ventral or dorsal surgical approach. That’s the primary finding of the multicenter randomized Cervical Spondylotic Myelopathy Surgical (CSM-S) trial, believed to be the first randomized study to compare alternative surgical approaches for this common condition. Results of the trial were published in the Journal of the American Medical Association (2021;325:942-951).

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Recent attention has focused on patient-reported quality of life for assessing surgical outcomes,” says the study’s senior author, Edward Benzel, MD, a neurosurgeon with Cleveland Clinic’s Center for Spine Health. “Ascertaining such information is especially important for cervical spondylotic myelopathy, given how often surgery is performed for this condition and the considerable practice variation in approaches.”

No consensus on optimal surgical approach to CSM

Cervical spondylotic myelopathy, the most common cause of spinal cord dysfunction, is frequently treated surgically in severe or progressive cases to decompress the spinal cord. In the U.S., ventral and dorsal decompression/fusion are the most common surgical interventions, but operations result in unsatisfactory outcomes in 30% of patients and frequently entail complications.

Evidence to date has failed to consistently show either the ventral or dorsal surgical approach to be superior to the other. The CSM-S trial was undertaken to compare the two strategies in terms of patient-reported physical functioning at one year.

Study design at a glance

The trial included patients with multilevel cervical spondylotic myelopathy from 14 large hospitals in the U.S. and one in Canada from April 2014 to March 2018. Patients were followed for up to two years.

The study’s 163 patients (mean age, 62 years; 49% women) were randomized to either ventral surgery (n = 63) or dorsal surgery (n = 100). Ventral surgery consisted of anterior cervical disk removal with instrumented fusion. Dorsal surgery consisted of either laminectomy with instrumented fusion or open-door laminoplasty, with the choice left to the surgeon’s discretion. Because of this variability in dorsal approaches, randomization followed a 2:3 scheme with more patients assigned to dorsal surgery.

Advertisement

One-year follow-up was conducted in 95% of study participants, and 80% completed two-year follow-up.

Results reveal few differences

The primary outcome was one-year change in the physical component summary score of the Short Form 36 Survey (SF-36 PCS), which assesses patient-reported physical functioning, limitations in work and activities due to pain, and physical and general health. Scores range from 0 to 100, with a change of 5 points or more considered clinically meaningful.

Mean improvements in one-year SF-36 PCS scores were not significantly different between the ventral surgery cohort (5.9 points) and the dorsal surgery group (6.2 points) (P = 0.86).

When the cohorts were compared across seven prespecified secondary outcomes, there were no significant differences between the groups on six of the outcomes — specifically, the modified Japanese Orthopaedic Association scale score, the Neck Disability Index, the EuroQol 5 Dimensions score, sagittal vertical axis, work status and heath resource utilization. The one exception was risk of any complications, which was significantly higher in the ventral surgery group than in the dorsal surgery group (48% vs. 24%; P = 0.002), driven largely by an excess of dysphagia with ventral surgery. There was no significant difference in incidence of major complications.

Key study takeaways

Dr. Benzel emphasizes two major points from this trial:

  • Ventral and dorsal surgeries result in similar improvements in patient-reported functioning. Both approaches were associated with meaningful clinical improvement at one and two years.
  • Surgery is effective for treating myelopathy, but complications are common. However, most complications were minor, including dysphagia, which resolved within the first postoperative year.

Advertisement

Laminectomy vs. laminoplasty: an unanswered question

The authors note that laminoplasty is preferred over ventral or dorsal fusion more often in Asia and Europe than in North America. Because of the small number of centers using laminoplasty in this study (five) and the nonrandomized protocol within the dorsal approach group, laminoplasty could not be adequately compared with the fusion procedures.

However, in nonrandomized analysis by treatment type, laminoplasty was associated with significantly better patient-reported functioning, fewer complications and less health resource utilization. The authors also note that reimbursement for laminoplasty is lower than for fusion in the U.S.

“Our findings on laminoplasty should be interpreted with caution,” Dr. Benzel concludes. “A more extensive evaluation — encompassing clinical and economic considerations — is needed to compare these three alternative surgical approaches. At the same time, the results associated with laminoplasty are very promising.”

Advertisement

Related Articles

Older man tending to houseplants

TEMPO-2 Trial Shows Promise for Tavapadon in Newly Diagnosed Parkinson’s Disease

The selective D1/D5 dopamine agonist provides symptom relief and improves daily function.

illustration of human brain with swirls of activity inside it
September 23, 2026/Neurosciences/Brain Health

Cleveland ADRC Renewal Boosts Research Into Alzheimer’s Progression

5-year funding award supports cohort expansion and deep phenotyping of AD and related dementias

young man meditating on a sofa
September 21, 2026/Neurosciences/Epilepsy

Lifestyle Interventions Show Promise as Adjunctive Epilepsy Management

Highest response rates seen with stress-lowering techniques like yoga, meditation and mindfulness

scan of brain anatomy with a blue arrow marking a point of interest
September 18, 2026/Neurosciences/Cerebrovascular

Pinpointing an Underrecognized Cause of Debilitating Headache

Digital subtraction myelography unveils often-overlooked but highly treatable underlying defect

medical students gathered around a large monitor showing a brain image
September 16, 2026/Neurosciences/Education

How Our New Building Will Double as a Neuro-Focused Mecca for Graduate Medical Education

Housing multidisciplinary clinicians in one leading-edge facility can transform GME along with patient care

stylized illustration of human spine against high-tech decorative background
September 14, 2026/Neurosciences/Spine Care

Promise and Progress in Using AI and Analytics to Improve Spine Surgery Practice

How ongoing efforts will be bolstered by Cleveland Clinic’s new Neurological Institute building

Man with polysomnography electrodes attached to his head
September 8, 2026/Neurosciences/Sleep Disorders

AI Model Stratifies Sleep-Based Risk and Clinical Outcomes

Foundation model reveals latent risk structures in sleep physiology that elude conventional metrics

portrait of Dr. Imad Najm against decorative background with podcast overlay
September 2, 2026/Neurosciences/Podcast

Integrating AI Into EEG Evaluation and Epilepsy Care (Podcast)

Where the field is moving and what Cleveland Clinic has in the works

Ad